Skip to main content
Premium Trial:

Request an Annual Quote

Integrated Genomics and Coda to Offer Combined Protein Expression Services

NEW YORK (GenomeWeb News) — Integrated Genomics yesterday said it has partnered with Coda Genomics to offer combined services for optimizing protein expression in humans, plants, and viruses.
IG said the collaboration creates an optimized protocol that uses its Pichia yeast-expression system with Coda translational protein expression.
“We provide the informatics, and Coda provides the methodology for optimization,” Vinayak Kapatral, IG’s vice president of business development. Kapatral, told GenomeWeb News.
He said IG will market the protocol, which clients can use on-site or can lease for their own use.
IG CEO and President John Elling said that coupling his company’s genomics sequences for Pichia and other cell lines technology with Coda’s translation engineering will “help increase yield and activity of difficult to express proteins.”
Financial terms of the agreement were not released.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.